Aveanna Healthcare Holdings Inc. (AVAH) Stock Analysis
Aveanna’s preferred-payor turnaround and California rate catalyst support upside, but $1.48 billion of debt and Medicaid exposure keep AVAH a measured re-rating story.
Overview
Aveanna Healthcare Holdings operates a diversified U.S. home-care platform serving medically complex pediatric and adult patients through Private Duty Services, Home Health & Hospice, and Medical Solutions. Its model shifts care from expensive institutional settings into the home, with more than 30 states of localized branch coverage and administrative infrastructure that smaller agencies cannot easily replicate. **The investment case is an operational turnaround supported by recurring demand, preferred-payor rate increases, and deleveraging.** Medicaid-related payors account for approximately 81% of revenue, creating both a durable reimbursement base and meaningful policy exposure. Q2 2026 revenue increased 13.7% to $670.5 million, adjusted EPS rose 22.2% to $0.22, and adjusted EBITDA reached $95.4 million, despite gross-margin pressure. Management raised 2026 guidance to revenue above $2.68 billion and adjusted EBITDA above $365 million, while increasing long-term organic growth targets to 5%-6% for PDS and 8%-10% for HHH. The principal catalyst is California’s January 1, 2027 pediatric nursing rate increase, preceded by planned wage investments from October 2026. At $12.32, valuation remains approximately 10.02x trailing GAAP earnings versus a 25.5x healthcare-services median, although leverage and Medicaid concentration constrain the risk profile.